- £50.15m
- £33.78m
- £49.53m
- 64
- 80
- 52
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Total Revenue | 70.9 | 71.5 | 74.5 | 49.7 | 49.5 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 60.3 | 62.9 | 70.1 | 56.2 | 44.3 |
Operating Profit | 10.6 | 8.63 | 4.37 | -6.53 | 5.23 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 10.5 | 8.56 | 4.34 | -6.76 | 5.33 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.84 | 6.89 | 3.6 | -7.25 | 4.32 |
Net Income Before Extraordinary Items | |||||
Net Income | 8.84 | 6.89 | 3.6 | -7.25 | 4.32 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 8.84 | 6.89 | 3.6 | -7.25 | 4.32 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.284 | 0.221 | 0.115 | -0.012 | 0.151 |
Dividends per Share |